Article Information
History
- September 8, 2020.
Article Versions
- Version 1 (June 25, 2020 - 04:06).
- Version 2 (June 27, 2020 - 11:00).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Daniel B. Larremore†,1,2,#,
- Bryan Wilder3,
- Evan Lester6,5,
- Soraya Shehata4,5,
- James M. Burke6,
- James A. Hay7,8,
- Milind Tambe3,
- Michael J. Mina‡,7,8,9,* and
- Roy Parker§,4,6,10,2,*
- 1Department of Computer Science, University of Colorado Boulder
- 2BioFrontiers Institute, University of Colorado at Boulder
- 3Center for Research on Computation & Society, Harvard John A Paulson School of Engineering and Applied Sciences, Harvard University
- 4Department of Molecular, Cellular and Developmental Biology, University of Colorado
- 5Medical Scientist Training Program, University of Colorado Anschutz Medical Campus
- 6Department of Biochemistry, University of Colorado Boulder
- 7Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health
- 8Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health
- 9Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
- 10Howard Hughes Medical Institute
- ↵#Corresponding author; email: daniel.larremore{at}colorado.edu
↵* These authors contributed equally.
Posted September 08, 2020.
Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance
